CDK7 inhibition as a promising therapeutic strategy for lung squamous cell carcinomas with a SOX2 amplification

[1]  Junior Tayou.  Identification of subsets of actionable genetic alterations in KRAS-mutant lung cancers using association rule mining , 2018, Cellular Oncology.

[2]  R. Young,et al.  High MITF Expression Is Associated with Super-Enhancers and Suppressed by CDK7 Inhibition in Melanoma. , 2018, The Journal of investigative dermatology.

[3]  J. Zuber,et al.  The novel BET bromodomain inhibitor BI 894999 represses super-enhancer-associated transcription and synergizes with CDK9 inhibition in AML , 2018, Oncogene.

[4]  J. Tyner,et al.  Super-Enhancers Promote Transcriptional Dysregulation in Nasopharyngeal Carcinoma. , 2017, Cancer research.

[5]  S. Chin,et al.  Therapeutic Rationale to Target Highly Expressed CDK7 Conferring Poor Outcomes in Triple-Negative Breast Cancer. , 2017, Cancer research.

[6]  G. O'Neill,et al.  Cyclin-dependent kinase 7 is a therapeutic target in high-grade glioma , 2017, Oncogenesis.

[7]  Allison P. Heath,et al.  Toward a Shared Vision for Cancer Genomic Data. , 2016, The New England journal of medicine.

[8]  J. Taipale,et al.  The role of enhancers in cancer , 2016, Nature Reviews Cancer.

[9]  D. Lin,et al.  Genetic alteration profiling of patients with resected squamous cell lung carcinomas , 2016, Oncotarget.

[10]  J. Park,et al.  Epidemiology of Lung Cancer in Korea: Recent Trends , 2016, Tuberculosis and respiratory diseases.

[11]  M. Guo,et al.  SOX2 suppresses CDKN1A to sustain growth of lung squamous cell carcinoma , 2016, Scientific Reports.

[12]  W. Kraus,et al.  No Driver behind the Wheel? Targeting Transcription in Cancer , 2015, Cell.

[13]  D. Price,et al.  THZ1 Reveals Roles for Cdk7 in Co-transcriptional Capping and Pausing. , 2015, Molecular cell.

[14]  Martin Vingron,et al.  Comprehensive genomic profiles of small cell lung cancer , 2015, Nature.

[15]  Huiyang Zhou,et al.  Genome-scale long noncoding RNA expression pattern in squamous cell lung cancer , 2015, Scientific Reports.

[16]  Guang-Biao Zhou,et al.  Tobacco smoke induces production of chemokine CCL20 to promote lung cancer. , 2015, Cancer letters.

[17]  L. Crinò,et al.  Nivolumab versus Docetaxel in Advanced Squamous-Cell Non-Small-Cell Lung Cancer. , 2015, The New England journal of medicine.

[18]  Nobhojit Roy,et al.  The Global Burden of Cancer 2013. , 2015, JAMA oncology.

[19]  P. Hammerman,et al.  Squamous Cell Lung Cancer: From Tumor Genomics to Cancer Therapeutics , 2015, Clinical Cancer Research.

[20]  L. Ouyang,et al.  Inhibition of BET bromodomains as a therapeutic strategy for cancer drug discovery , 2015, Oncotarget.

[21]  D. MacPherson,et al.  Treating transcriptional addiction in small cell lung cancer. , 2014, Cancer cell.

[22]  Yan Liu,et al.  Targeting transcriptional addictions in small cell lung cancer with a covalent CDK7 inhibitor. , 2014, Cancer cell.

[23]  Bandana Sharma,et al.  CDK7 Inhibition Suppresses Super-Enhancer-Linked Oncogenic Transcription in MYCN-Driven Cancer , 2014, Cell.

[24]  Aristotelis Tsirigos,et al.  Control of Embryonic Stem Cell Identity by BRD4-Dependent Transcriptional Elongation of Super-Enhancer-Associated Pluripotency Genes , 2014, Cell reports.

[25]  Vandana G Abramson,et al.  Molecular Heterogeneity of Triple-Negative Breast Cancer , 2014, Current Breast Cancer Reports.

[26]  Sridhar Ramaswamy,et al.  Targeting transcription regulation in cancer with a covalent CDK7 inhibitor , 2014, Nature.

[27]  D. Stupack,et al.  SOX2 regulates apoptosis through MAP4K4-survivin signaling pathway in human lung cancer cells. , 2014, Carcinogenesis.

[28]  Yong Soo Choi,et al.  Integrative and comparative genomic analysis of lung squamous cell carcinomas in East Asian patients. , 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[29]  R. Young,et al.  Super-Enhancers in the Control of Cell Identity and Disease , 2013, Cell.

[30]  Doris Berger,et al.  International Cancer Genome Consortium , 2013, Im Focus Onkologie.

[31]  K. Ozato,et al.  BRD4 Coordinates Recruitment of Pause Release Factor P-TEFb and the Pausing Complex NELF/DSIF To Regulate Transcription Elongation of Interferon-Stimulated Genes , 2013, Molecular and Cellular Biology.

[32]  G. Bejerano,et al.  Enhancers: five essential questions , 2013, Nature Reviews Genetics.

[33]  Chao Zhang,et al.  Cyclin-dependent kinase control of the initiation-to-elongation switch of RNA polymerase II , 2012, Nature Structural &Molecular Biology.

[34]  Li Ding,et al.  Genomic Landscape of Non-Small Cell Lung Cancer in Smokers and Never-Smokers , 2012, Cell.

[35]  Steven J. M. Jones,et al.  Comprehensive genomic characterization of squamous cell lung cancers , 2012, Nature.

[36]  M. Barbacid,et al.  Genetic inactivation of Cdk7 leads to cell cycle arrest and induces premature aging due to adult stem cell exhaustion , 2012, The EMBO journal.

[37]  Elisabeth Brambilla,et al.  Squamous Cell Carcinoma of the Lung: Molecular Subtypes and Therapeutic Opportunities , 2012, Clinical Cancer Research.

[38]  Yun Lu,et al.  Evidence That SOX2 Overexpression Is Oncogenic in the Lung , 2010, PloS one.

[39]  Dirk Eick,et al.  TFIIH kinase places bivalent marks on the carboxy-terminal domain of RNA polymerase II. , 2009, Molecular cell.

[40]  Bryan J Venters,et al.  How eukaryotic genes are transcribed , 2009, Critical reviews in biochemistry and molecular biology.

[41]  Brad T. Sherman,et al.  Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists , 2008, Nucleic acids research.

[42]  G A Colditz,et al.  Comparison of aspects of smoking among the four histological types of lung cancer , 2008, Tobacco Control.

[43]  K. Struhl,et al.  The transition from transcriptional initiation to elongation. , 2008, Current opinion in genetics & development.

[44]  Xiaomei Ma,et al.  Global Burden of Cancer , 2006, The Yale journal of biology and medicine.

[45]  C. Roussos,et al.  Cytogenetic and molecular aspects of lung cancer. , 2006, Cancer letters.

[46]  J. Minna,et al.  Molecular genetics of small cell lung carcinoma. , 2001, Seminars in oncology.

[47]  Brad T. Sherman,et al.  Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources , 2008, Nature Protocols.

[48]  A. Fine.  Recent trends. , 2003, Managed care quarterly.